针对小细胞肺癌的基于抗体的治疗方法:叙述性审查
Andrea Torchia1,2, Giuliana Ciappina3, Maristella Giammaruco2
1Clinical and Molecular Medicine, Sapienza - Università di Roma, Rome, Italy.
Biologics : targets & therapy
|April 22, 2025
概括
新型基于抗体的疗法,包括T细胞参与剂和抗体药物合物,在治疗选择有限的晚期小细胞肺癌 (SCLC) 方面表现有前途.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 药物开发 药物开发
背景情况:
- 小细胞肺癌 (SCLC) 具有高度的攻击性,对于晚期的治疗选择有限.
- 对于在SCLC的第一线治疗后进展的患者,存在很少的治疗选择.
- 基于抗体的疗法正在成为各种固体瘤的有希望的途径,包括SCLC.
研究的目的:
- 审查基于抗体的新型疗法在治疗小细胞肺癌中的新兴作用.
- 在SCLC治疗中突出突出一些有前途的药物,如T细胞参与剂和抗体-药物联合体 (ADC).
- 讨论这些新药在一个尚未满足治疗需求的领域的潜力.
主要方法:
- 对SCLC抗体治疗的临床试验数据的审查.
- 专注于T细胞参与剂 (例如Tarlatamab) 和ADCs (例如Ifinatamab-deruxtecan,Sacituzumab govitecan).
- 包括针对VEGF和PD-(L) 1的两种特异性抗体,以及其他早期阶段药物.
主要成果:
- 塔拉塔马布 (DLL3导向的T细胞参与者) 在第二阶段研究中显示出有效性.
- 伊菲纳塔马巴-德鲁克斯坦 (抗B7-H3ADC) 在预先治疗的SCLC患者中显示出有效性.
- 在TROPiCS-03试验中,sacituzumab govitecan (Trop-2-导向的ADC) 产生了积极的结果.
- 针对VEGF和PD-(L) 1的双特异性抗体在早期试验中表现出抗瘤活性.
- 其他早期发展中的基于抗体的药物显示出有前途的活性.
结论:
- 新型基于抗体的药物具有显著的潜力,可以在SCLC治疗中发挥重要作用.
- 这些疗法在很少可用的治疗选择的领域提供了新的希望.
- 目前正在进行第三期试验,以进一步评估疗效,并与当前的护理标准进行比较.
更多相关视频
07:43Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
10.5K
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.5K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:49Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
01:27Tumor Immunotherapy
398
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
398